Stroke, CardiovascularBCARNCT04989920
Brain and Behavior Correlates of Arm Rehabilitation
A study testing Experimental group: CIMT group (Constraint-Induced Movement Therapy) in people with Stroke, Cardiovascular, run by University of Southern California at 1 site in United States.
Trial summary
This project is designed to use three-dimensional movement analysis and magnetic resonance (fMRI) neuroimaging techniques to examine the brain activity and motor behavior changes associated with constraint-induced (CI) therapy for patients with sub-acute stroke (3-9 months post-stroke).Participants are evaluated at 5… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke, Cardiovascular
- What is being tested?
- Experimental group: CIMT group (Constraint-Induced Movement Therapy)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 23 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Apr 2003to 15 Jul 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 1. 3 - 9 months post first-time stroke of infarct hemorrhagic type at the beginning of participation.
- 2. over the age of 18 years with no upper age limit.
- 3. cleared by a medical physician to participate.
- 4. Independent in basic activities of living.
- 5. minimum motor criteria: at least 10 degrees of active wrist extension, 10 degrees of finger extension in at least two fingers and the thumb (abduction) and the elbow (90 degrees flexion and extension) and shoulder (45 degrees flexion and abduction motion criteria.
Who cannot join
- 1. score below 24 on the Folstein Mini-mental status exam (MMSE)
- 2. score greater than an average of 2.5 on the Motor Activity Log (MAL) amount scale
- 3. are concurrently participating in any experimental drug study
- 4. are concurrently participating in any formal physical rehabilitation or clinical trials
- 5. do not meet the minimum motor criteria or who do not meet the minimum balance criteria.
- 6. pre-menopausal woman who is pregnant
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Southern California
Los Angeles, California, 90089
About this study
This project is designed to use three-dimensional movement analysis and magnetic resonance (fMRI) neuroimaging techniques to examine the brain activity and motor behavior changes associated with constraint-induced (CI) therapy for patients with sub-acute stroke (3-9 months post-stroke).Participants are evaluated at 5 time points-1-mo (pre \& post), 6-mo (pre \& post), and 12-mo. Each person is randomized to receive CI therapy either between pre- and post-evaluations or after the 6-mo pre-evaluation. We will determine the effects of CI therapy on 1) reaching and grasping actions using behavioral kinematics and 2) the sensorimotor network through fMRI scans with goal-directed aiming and grasping tasks. We will also determine the relationship between lesion size and location using 3-D volumetric MRI scans and behavioral outcomes as a consequence of CI therapy.
Read the detailed description
PURPOSE OF THE STUDY AND BACKGROUND
- Specific Aims and Purpose of The Study: Overall, this proposal is to use three-dimensional movement analysis and magnetic resonance (fMRI) neuroimaging techniques to examine the brain activity and motor behavior changes associated with constraint-induced (CI) therapy for patients with sub-acute stroke. This project is a companion study to the recently funded multi-center randomized clinical trial (HD37606-01), Extremity Constraint-Induced Therapy Evaluation (EXCITE). This project complements EXCITE by probing the mechanisms underlying the clinical intervention in stroke rehabilitation. However, since enrollment for EXCITE has been completed, we will be enrolling a new set of participants.
- SPECIFIC AIMS:
- Determine the relationship between lesion size and location as assessed using 3-D volumetric MRI and functional outcome (i.e, motor control and functional use) as a consequence of CI therapy.
- Determine the effects of CI therapy on the control of reaching and grasping actions as assessed using behavioral kinematics.
- Determine the effects of CI therapy on the neural substrate (sensorimotor network) as assessed using fMRI during goal-directed aiming and grasping tasks (performed as activation tasks in the scanner).
- Determine the persistence and or stability of these changes in, motor control, neural substrate, and functional use of the upper extremity in stroke with CI therapy 6 months later.
A.1: Specific working hypotheses for each aim are:
For Specific Aim # 1, Hypothesis 1: There will be a predictable relationship between lesion location, size and functional outcome from CI therapy. Those with specific sensorimotor cortex (MI, SI) lesions will show a poorer response than those with lesions confined to the subcortical regions (e.g., posterior limb of internal capsule, subcortical white matter, or basis pontis, paramedian pontine areas) controlled for lesion size. One working assumption underlying this hypothesis is that there will be a differential effect of CI therapy with subcortical vs cortical sensorimotor area lesions. Hypothesis 2: The differences between groups (treated vs untreated) will be greater in those with subcortical lesions than in those with cortical sensorimotor area lesions, controlled for lesion size, at the post-test/intervention time point.
For Specific Aim # 2, Hypothesis 1: CI therapy will benefit the control of reaching and grasping actions through changes in (arm) transport duration, timing of peak aperture, peak transport velocity, and smoothness of both the reach and the grasp component for grasping different sized objects and reaching different distances. Hypothesis # 2 is that the change in the motor control of reaching and grasping actions from baseline to post-test/intervention time point will be greater in the treated compared to the untreated group. Hypothesis # 3 is that these motor control changes will be correlated with changes in real-world use of the upper extremity as indexed by the Motor Activity Log (MAL) and Wolf Motor Function Test (WMFT).
For Specific Aim # 3, Hypothesis 1: CI therapy will result in a decrease in ipsilateral hemisphere activation and an expanded extent and or increased intensity of specific regions of interest (ROIs) in the contralateral (affected) sensorimotor network with CI therapy. Specifically, and as it relates to the planning of more complex hand actions (i.e., precision grasp), specific ROIs that will show change in intensity and/or extent include primary motor cortex (MI), primary sensory cortex (S1), supplementary motor area (SMA), and premotor area (PM). Hypothesis # 2 is that the change in ROI activation from baseline to post-test/intervention time point will be greater in the treated compared to the untreated group. Hypothesis 3: The presence of an expanded extent and/or more intense activation in these contralateral hemisphere ROIs will be correlated with changes in real-world use of the upper extremity as indexed by the MAL and WMFT.
For Specific Aim # 4, Hypothesis 1: Persistence of these changes in reach-to-grasp motor control (behavioral kinematics), expanded extent/intensity of sensorimotor network ROIs (fMRI) and functional use (MAL and WMFT) will be demonstrated through comparison of the treated and untreated (delayed-intervention) groups at the 6-month follow-up point. It is possible that the differences between groups at the 6-month point may be greater than at the post-test/intervention point particularly if functional use continues to improve in the treated group.
- Background and Significance: Stroke is the leading cause of disability among American adults. Each year in the U.S., approximately 750,000 people suffer strokes and of those, nearly 400,000 survive with some level of neurological impairment and disability. The cumulative total of living, stroke-affected Americans is nearly 3 million. Thirty billion dollars annually is the estimated burden from stroke-related disability. Despite the enormity of these statistics, there have been almost no scientific studies of the effectiveness of post-stroke rehabilitation interventions. As a result, the recently published Clinical practice guidelines for post-stroke rehabilitation (Gresham et al., 1995) have been forced to rely primarily on expert opinion and not on well-controlled scientific studies.
A new therapeutic approach to the rehabilitation of movement after stroke, termed constraint-induced (CI) movement therapy, has been derived from basic research with monkeys given somatosensory deafferentation (Taub, 1980). CI movement therapy consists of a family of therapies; their common element is that they induce stroke patients to greatly increase the use of an affected arm and hand for many hours a day over a period of 10 to 14 consecutive days. The signature intervention involves motor restriction of the less affected arm in a sling or mitt and training of the affected arm. The therapies result in large changes in amount of use of the affected arm in the activities of daily living outside of the clinic that have persisted for the 2 years measured to date (Morris et al., 1997; Taub \& Wolf, 1997; Taub et al., 1994; Taub et al., 1993; Wolf et al., 1989). Previous research has never resulted in any adverse effects from the restraint on the "good arm/hand".
There is mounting evidence for cortical reorganization that accompanies recovery of motor control after stroke, and recently, similar changes were demonstrated in connection with CI therapy in chronic stroke (Liepert et al., 2000). There appears to be a relationship between lesion size and location and the nature of this reorganization as well as the time course of this reorganization (Azari \& Seitz, 2000). The fact that therapy (forced use) can influence this reorganization as revealed by the sub-human primate work (Nudo et al., 1996a,b) suggests that there would be differences in the change in cortical activation patterns for reaching and grasping tasks from baseline to post-test/intervention time points between the treated and untreated subjects in our proposed project. Further, and related to the neural network for the control of uni-manual reaching and grasping actions, ipsilateral (or bilateral) hemisphere activation has been shown to be a corollary of task complexity, motor set, and excessive effort (Winstein et al., 1997; Chen et al., 1997a, 1997b; Beltramello et al., 1998; Doyon et al.,1998; Winstein et al., 2000). Motor set effects have been demonstrated most consistently in the motor control literature by comparing predictable and unpredictable order conditions. In an unpredictable condition, motor set is based on a 'best guess' plan and default parameters are selected based on the range of possible responses (see Winstein et al., 2000, for motor set effects in triggered grasp responses). By contrast, under predictable task conditions, a more precise and tuned plan is enabled as the exact response can be planned in advance (Velicki et al., 2000). As such, we hypothesize that as reaching and grasping actions improve with practice, 'task complexity' will be reduced, motor set effects will be enhanced (i.e., the task is planned and performed more easily, with less cognitive demand, Lee et al., 1994), and there should be a concomitant reduction in the extent of ipsilateral (bilateral) neural activity for affected limb movements. At the same time, and consistent with use-dependent cortical reorganization, as skill (learning) improves, there should be an expansion or increased intensity of activation in the appropriate contralateral neural networks of reaching and grasping actions, particularly in regions of interest including M1, S1, SMA and PM areas. These arguments provide the logic for Specific Aim # 3 to determine the changes, as a consequence of CI therapy, in the sensorimotor cortical network through event-related fMRI during specific reaching and grasping tasks, and our associated hypotheses.
By logical extension, we suggest that the effects of CI therapy on the control of upper extremity reaching and grasping actions can be indexed at both the level of cortical neural activation patterns (fMRI) and behavioral kinematics and in relation to well known psychophysical laws of motor learning and control. Further, we suggest that the changes in performance as reflected by physiological brain activation and motor control kinematics can be related to changes in the use of the affected upper extremity as indexed by MAL and WMFT. This companion project is innovative in that it represents the first attempt to correlate the results of psychophysical studies of the 'control' of reaching and grasping actions with neuroimaging (fMRI) studies designed to highlight the 'central motor set' effect (Winstein et al., 2000) using a repeated measures design (3 repeated tests) with a between group factor (treated and untreated-control group). This study complements current research in the exploration of brain activity changes using different motor activation tasks and circumstances that are geared to lend science to the examination of this clinically based therapy.
With this proposal, we plan to assess the changes in neural activation (cortical reorganization) and motor control of reaching and grasping actions that pertain directly to CI therapy compared to that associated with standard and customary care. These experiments will be done on a separate day from the baseline, post-test, and 6-month follow-up tests, but they will be scheduled within 1 week of those tests. This design allows us to explore the physiological neural circuits, and motor control variables mediating the expected behavioral change associated with CI therapy (treated group) and standard and customary care (delayed intervention group) and characterize the persistence of that change in a group of sub-acute stroke survivors who have relatively small lesions and some ability to move the wrist and fingers on the hemiparetic side.
- Conditions
- Stroke, Cardiovascular
- Being tested
- Experimental group: CIMT group (Constraint-Induced Movement Therapy)
- Keywords
- Constraint-Induced Movement Therapy
- Medical subject headings
- Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Experimental group: CIMT group (Constraint-Induced Movement Therapy)Behavioural
Also called CI group
2 weeks of intensive therapy delivered 5d/week for 6 hrs/day
| Study group | Role | What they receive |
|---|---|---|
| CIMT (Constraint-Induced Movement Therapy) | Experimental | Therapy intervention: This arm will deliver the signature Constraint-induced therapy protocol for 60 hrs of training over a two-week period. Receives: Behavioral: Experimental group: CIMT group (Constraint-Induced Movement Therapy) |
| Delayed (Control) intervention group | No intervention | Subjects randomized to the delayed intervention group will receive the "usual and customary" services provided by their personal health care system. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Wolf Motor Function test
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Measured: Baseline to Immediately post-intervention
Change in Wolf Motor Function test
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Measured: Immediately post-intervention to 6-month follow-up
Change in Wolf Motor Function test
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Measured: Immediately post-intervention to 1 year follow-up
Change Motor activity log
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Measured: Baseline to Immediately post-intervention
Change Motor activity log
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Measured: Immediately post-intervention to 6 months follow-up
Secondary outcomes (1)
Change in Laterality-Index
Brain activation measure for two regions of interest: M1 and Pre-frontal cortex
Measured: Baseline to Immediately post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Aug 2021
- Study start28 Apr 2003
- Primary completion30 Jun 2005
- Study completion15 Jul 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Stroke, CardiovascularStudies of the same condition, open and under way.
- More trials run by University of Southern CaliforniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Two group (treated vs waitlisted) crossover design.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 23 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Southern California
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA)
- Responsible party
- Principal investigator, Carolee Winstein, University of Southern California
- Investigators
- Carolee J Winstein, PhD, Principal investigator, Company Name (optional)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04989920
- Sponsor's protocol ID
- HS-016022
- Other IDs
- R24HD039629, F31HD098796, RR12169, RR13642, RR08655, K12DA000167, 14CRP18200010, R01NS045485
- Acronym
- BCAR
- Status last verified
- Aug 2021
- First submitted
- 25 Jul 2021
- Last updated
- 4 Aug 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Only secondary and exploratory data analysis analysis code will be shared with other researchers.
Publications
Tan C, Tretriluxana J, Pitsch E, Runnarong N, Winstein CJ. Anticipatory planning of functional reach-to-grasp: a pilot study. Neurorehabil Neural Repair. 2012 Oct;26(8):957-67. doi: 10.1177/1545968312437938. Epub 2012 Mar 20.
PubMed 22434022Dong Y, Dobkin BH, Cen SY, Wu AD, Winstein CJ. Motor cortex activation during treatment may predict therapeutic gains in paretic hand function after stroke. Stroke. 2006 Jun;37(6):1552-5. doi: 10.1161/01.STR.0000221281.69373.4e. Epub 2006 Apr 27.
PubMed 16645139Dong Y, Winstein CJ, Albistegui-DuBois R, Dobkin BH. Evolution of FMRI activation in the perilesional primary motor cortex and cerebellum with rehabilitation training-related motor gains after stroke: a pilot study. Neurorehabil Neural Repair. 2007 Sep-Oct;21(5):412-28. doi: 10.1177/1545968306298598. Epub 2007 Mar 16.
PubMed 17369516
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Brain and Behavior Correlates of Arm Rehabilitation
- ClinicalTrials.gov ID
- NCT04989920
- Acronym / sponsor ID
- BCAR / HS-016022
- Conditions
- Stroke, Cardiovascular
- Keywords
- Constraint-Induced Movement Therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 23 participants (actual)
- Lead sponsor
- University of Southern CaliforniaUniversity, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA)
- Study start
- 28 Apr 2003 (actual)
- Primary completion
- 30 Jun 2005 (actual)
- Study completion
- 15 Jul 2011 (actual)
- First posted
- 4 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project is designed to use three-dimensional movement analysis and magnetic resonance (fMRI) neuroimaging techniques to examine the brain activity and motor behavior changes associated with constraint-induced (CI) therapy for patients with sub-acute stroke (3-9 months post-stroke).Participants are evaluated at 5 time points-1-mo (pre \& post), 6-mo (pre \& post), and 12-mo. Each person is randomized to receive CI therapy either between pre- and post-evaluations or after the 6-mo pre-evaluation. We will determine the effects of CI therapy on 1) reaching and grasping actions using behavioral kinematics and 2) the sensorimotor network through fMRI scans with goal-directed aiming and grasping tasks. We will also determine the relationship between lesion size and location using 3-D volumetric MRI scans and behavioral outcomes as a consequence of CI therapy.
Detailed description
PURPOSE OF THE STUDY AND BACKGROUND
- Specific Aims and Purpose of The Study: Overall, this proposal is to use three-dimensional movement analysis and magnetic resonance (fMRI) neuroimaging techniques to examine the brain activity and motor behavior changes associated with constraint-induced (CI) therapy for patients with sub-acute stroke. This project is a companion study to the recently funded multi-center randomized clinical trial (HD37606-01), Extremity Constraint-Induced Therapy Evaluation (EXCITE). This project complements EXCITE by probing the mechanisms underlying the clinical intervention in stroke rehabilitation. However, since enrollment for EXCITE has been completed, we will be enrolling a new set of participants.
- SPECIFIC AIMS:
- Determine the relationship between lesion size and location as assessed using 3-D volumetric MRI and functional outcome (i.e, motor control and functional use) as a consequence of CI therapy.
- Determine the effects of CI therapy on the control of reaching and grasping actions as assessed using behavioral kinematics.
- Determine the effects of CI therapy on the neural substrate (sensorimotor network) as assessed using fMRI during goal-directed aiming and grasping tasks (performed as activation tasks in the scanner).
- Determine the persistence and or stability of these changes in, motor control, neural substrate, and functional use of the upper extremity in stroke with CI therapy 6 months later.
A.1: Specific working hypotheses for each aim are:
For Specific Aim # 1, Hypothesis 1: There will be a predictable relationship between lesion location, size and functional outcome from CI therapy. Those with specific sensorimotor cortex (MI, SI) lesions will show a poorer response than those with lesions confined to the subcortical regions (e.g., posterior limb of internal capsule, subcortical white matter, or basis pontis, paramedian pontine areas) controlled for lesion size. One working assumption underlying this hypothesis is that there will be a differential effect of CI therapy with subcortical vs cortical sensorimotor area lesions. Hypothesis 2: The differences between groups (treated vs untreated) will be greater in those with subcortical lesions than in those with cortical sensorimotor area lesions, controlled for lesion size, at the post-test/intervention time point.
For Specific Aim # 2, Hypothesis 1: CI therapy will benefit the control of reaching and grasping actions through changes in (arm) transport duration, timing of peak aperture, peak transport velocity, and smoothness of both the reach and the grasp component for grasping different sized objects and reaching different distances. Hypothesis # 2 is that the change in the motor control of reaching and grasping actions from baseline to post-test/intervention time point will be greater in the treated compared to the untreated group. Hypothesis # 3 is that these motor control changes will be correlated with changes in real-world use of the upper extremity as indexed by the Motor Activity Log (MAL) and Wolf Motor Function Test (WMFT).
For Specific Aim # 3, Hypothesis 1: CI therapy will result in a decrease in ipsilateral hemisphere activation and an expanded extent and or increased intensity of specific regions of interest (ROIs) in the contralateral (affected) sensorimotor network with CI therapy. Specifically, and as it relates to the planning of more complex hand actions (i.e., precision grasp), specific ROIs that will show change in intensity and/or extent include primary motor cortex (MI), primary sensory cortex (S1), supplementary motor area (SMA), and premotor area (PM). Hypothesis # 2 is that the change in ROI activation from baseline to post-test/intervention time point will be greater in the treated compared to the untreated group. Hypothesis 3: The presence of an expanded extent and/or more intense activation in these contralateral hemisphere ROIs will be correlated with changes in real-world use of the upper extremity as indexed by the MAL and WMFT.
For Specific Aim # 4, Hypothesis 1: Persistence of these changes in reach-to-grasp motor control (behavioral kinematics), expanded extent/intensity of sensorimotor network ROIs (fMRI) and functional use (MAL and WMFT) will be demonstrated through comparison of the treated and untreated (delayed-intervention) groups at the 6-month follow-up point. It is possible that the differences between groups at the 6-month point may be greater than at the post-test/intervention point particularly if functional use continues to improve in the treated group.
- Background and Significance: Stroke is the leading cause of disability among American adults. Each year in the U.S., approximately 750,000 people suffer strokes and of those, nearly 400,000 survive with some level of neurological impairment and disability. The cumulative total of living, stroke-affected Americans is nearly 3 million. Thirty billion dollars annually is the estimated burden from stroke-related disability. Despite the enormity of these statistics, there have been almost no scientific studies of the effectiveness of post-stroke rehabilitation interventions. As a result, the recently published Clinical practice guidelines for post-stroke rehabilitation (Gresham et al., 1995) have been forced to rely primarily on expert opinion and not on well-controlled scientific studies.
A new therapeutic approach to the rehabilitation of movement after stroke, termed constraint-induced (CI) movement therapy, has been derived from basic research with monkeys given somatosensory deafferentation (Taub, 1980). CI movement therapy consists of a family of therapies; their common element is that they induce stroke patients to greatly increase the use of an affected arm and hand for many hours a day over a period of 10 to 14 consecutive days. The signature intervention involves motor restriction of the less affected arm in a sling or mitt and training of the affected arm. The therapies result in large changes in amount of use of the affected arm in the activities of daily living outside of the clinic that have persisted for the 2 years measured to date (Morris et al., 1997; Taub \& Wolf, 1997; Taub et al., 1994; Taub et al., 1993; Wolf et al., 1989). Previous research has never resulted in any adverse effects from the restraint on the "good arm/hand".
There is mounting evidence for cortical reorganization that accompanies recovery of motor control after stroke, and recently, similar changes were demonstrated in connection with CI therapy in chronic stroke (Liepert et al., 2000). There appears to be a relationship between lesion size and location and the nature of this reorganization as well as the time course of this reorganization (Azari \& Seitz, 2000). The fact that therapy (forced use) can influence this reorganization as revealed by the sub-human primate work (Nudo et al., 1996a,b) suggests that there would be differences in the change in cortical activation patterns for reaching and grasping tasks from baseline to post-test/intervention time points between the treated and untreated subjects in our proposed project. Further, and related to the neural network for the control of uni-manual reaching and grasping actions, ipsilateral (or bilateral) hemisphere activation has been shown to be a corollary of task complexity, motor set, and excessive effort (Winstein et al., 1997; Chen et al., 1997a, 1997b; Beltramello et al., 1998; Doyon et al.,1998; Winstein et al., 2000). Motor set effects have been demonstrated most consistently in the motor control literature by comparing predictable and unpredictable order conditions. In an unpredictable condition, motor set is based on a 'best guess' plan and default parameters are selected based on the range of possible responses (see Winstein et al., 2000, for motor set effects in triggered grasp responses). By contrast, under predictable task conditions, a more precise and tuned plan is enabled as the exact response can be planned in advance (Velicki et al., 2000). As such, we hypothesize that as reaching and grasping actions improve with practice, 'task complexity' will be reduced, motor set effects will be enhanced (i.e., the task is planned and performed more easily, with less cognitive demand, Lee et al., 1994), and there should be a concomitant reduction in the extent of ipsilateral (bilateral) neural activity for affected limb movements. At the same time, and consistent with use-dependent cortical reorganization, as skill (learning) improves, there should be an expansion or increased intensity of activation in the appropriate contralateral neural networks of reaching and grasping actions, particularly in regions of interest including M1, S1, SMA and PM areas. These arguments provide the logic for Specific Aim # 3 to determine the changes, as a consequence of CI therapy, in the sensorimotor cortical network through event-related fMRI during specific reaching and grasping tasks, and our associated hypotheses.
By logical extension, we suggest that the effects of CI therapy on the control of upper extremity reaching and grasping actions can be indexed at both the level of cortical neural activation patterns (fMRI) and behavioral kinematics and in relation to well known psychophysical laws of motor learning and control. Further, we suggest that the changes in performance as reflected by physiological brain activation and motor control kinematics can be related to changes in the use of the affected upper extremity as indexed by MAL and WMFT. This companion project is innovative in that it represents the first attempt to correlate the results of psychophysical studies of the 'control' of reaching and grasping actions with neuroimaging (fMRI) studies designed to highlight the 'central motor set' effect (Winstein et al., 2000) using a repeated measures design (3 repeated tests) with a between group factor (treated and untreated-control group). This study complements current research in the exploration of brain activity changes using different motor activation tasks and circumstances that are geared to lend science to the examination of this clinically based therapy.
With this proposal, we plan to assess the changes in neural activation (cortical reorganization) and motor control of reaching and grasping actions that pertain directly to CI therapy compared to that associated with standard and customary care. These experiments will be done on a separate day from the baseline, post-test, and 6-month follow-up tests, but they will be scheduled within 1 week of those tests. This design allows us to explore the physiological neural circuits, and motor control variables mediating the expected behavioral change associated with CI therapy (treated group) and standard and customary care (delayed intervention group) and characterize the persistence of that change in a group of sub-acute stroke survivors who have relatively small lesions and some ability to move the wrist and fingers on the hemiparetic side.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Two group (treated vs waitlisted) crossover design.
| Arm | Type | Receives |
|---|---|---|
| CIMT (Constraint-Induced Movement Therapy) | Experimental | Behavioral: Experimental group: CIMT group (Constraint-Induced Movement Therapy)Therapy intervention: This arm will deliver the signature Constraint-induced therapy protocol for 60 hrs of training over a two-week period. |
| Delayed (Control) intervention group | No intervention | –Subjects randomized to the delayed intervention group will receive the "usual and customary" services provided by their personal health care system. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- 1. 3 - 9 months post first-time stroke of infarct hemorrhagic type at the beginning of participation.
- 2. over the age of 18 years with no upper age limit.
- 3. cleared by a medical physician to participate.
- 4. Independent in basic activities of living.
- 5. minimum motor criteria: at least 10 degrees of active wrist extension, 10 degrees of finger extension in at least two fingers and the thumb (abduction) and the elbow (90 degrees flexion and extension) and shoulder (45 degrees flexion and abduction motion criteria.
Key exclusion criteria (6 listed)
- 1. score below 24 on the Folstein Mini-mental status exam (MMSE)
- 2. score greater than an average of 2.5 on the Motor Activity Log (MAL) amount scale
- 3. are concurrently participating in any experimental drug study
- 4. are concurrently participating in any formal physical rehabilitation or clinical trials
- 5. do not meet the minimum motor criteria or who do not meet the minimum balance criteria.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Experimental group: CIMT group (Constraint-Induced Movement Therapy)Also: CI group2 weeks of intensive therapy delivered 5d/week for 6 hrs/day | Behavioural | CIMT (Constraint-Induced Movement Therapy) |
Primary outcome
Change in Wolf Motor Function test
Time frame: Baseline to Immediately post-intervention
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Change in Wolf Motor Function test
Time frame: Immediately post-intervention to 6-month follow-up
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Change in Wolf Motor Function test
Time frame: Immediately post-intervention to 1 year follow-up
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Change Motor activity log
Time frame: Baseline to Immediately post-intervention
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
Change Motor activity log
Time frame: Immediately post-intervention to 6 months follow-up
The primary outcome measure for BCAR and to which we will correlate our brain and behavior measures are the Wolf motor function test (Wolf et al., 2001) and the Motor Activity Log (a semi-structured interview) of arm use for 30 ADL in the home. These measures of arm use capture arm function in the laboratory and in the real world and have acceptable psychometric properties.
1 secondary outcome
Change in Laterality-Index
Time frame: Baseline to Immediately post-intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2021.
- Background: PubMed 22434022Tan C, Tretriluxana J, Pitsch E, Runnarong N, Winstein CJ. Anticipatory planning of functional reach-to-grasp: a pilot study. Neurorehabil Neural Repair. 2012 Oct;26(8):957-67. doi: 10.1177/1545968312437938. Epub 2012 Mar 20.
- Results publication: PubMed 16645139Dong Y, Dobkin BH, Cen SY, Wu AD, Winstein CJ. Motor cortex activation during treatment may predict therapeutic gains in paretic hand function after stroke. Stroke. 2006 Jun;37(6):1552-5. doi: 10.1161/01.STR.0000221281.69373.4e. Epub 2006 Apr 27.
- Results publication: PubMed 17369516Dong Y, Winstein CJ, Albistegui-DuBois R, Dobkin BH. Evolution of FMRI activation in the perilesional primary motor cortex and cerebellum with rehabilitation training-related motor gains after stroke: a pilot study. Neurorehabil Neural Repair. 2007 Sep-Oct;21(5):412-28. doi: 10.1177/1545968306298598. Epub 2007 Mar 16.
- Individual participant dataSharing planned: No. Only secondary and exploratory data analysis analysis code will be shared with other researchers.
Related trials for Stroke, Cardiovascular
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carolee J Winstein, PhD principal investigator
Company Name (optional)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Experimental group: CIMT group (Constraint-Induced Movement Therapy) in people with Stroke, Cardiovascular, run by University of Southern California at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Wolf Motor Function test (time frame: Baseline to Immediately post-intervention). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04989920, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2021.